Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fadil Masskouri"'
Autor:
Olivier Bouché, Marie-Christine Etienne-Grimaldi, Karine Le Malicot, Jean-Christophe Boyer, Jean-François Seitz, Joseph Ciccolini, Jean-Louis Legoux, Thierry André, Marie-Anne Loriot, Chantal Barin-Le-Guellec, Joël Guigay, Pierre Michel, Fabienne Thomas, David Malka, Paolo Carni, Juliette Thariat, Fadil Masskouri, Roger Faroux, Suzette Delaloge
Publikováno v:
Bulletin du Cancer. 106:759-775
Dihydropyrimidine dehydrogenase (DPD) deficiency is the main cause of early severe toxicities induced by fluoropyrimidines (FP). The French Group of Clinical Oncopharmacology (GPCO)-Unicancer and the French Pharmacogenetics Network (RNPGx) initiated
Autor:
Xavier Fonrose, Bernard Royer, Sylvie Quaranta, Anne-Sophie Wozny, Nicolas Picard, Vianney Poinsignon, Fadil Masskouri, Antonin Schmitt, Jean-Christophe Boyer, Franck Broly, Fabienne Thomas, Gérard Milano, Céline Narjoz, Claire Lafay-Chebassier, Joseph Ciccolini, Céline Verstuyft, Angelo Paci, Christine Bobin-Dubigeon, Alexandre Harlé, Marie-Christine Etienne-Grimaldi, Alexandre Evrard, Benjamin Hennart, Laurent Becquemont, Marie-Anne Loriot, Chantal Barin-Le-Guellec
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (4), pp.397-407. ⟨10.1016/j.bulcan.2018.02.001⟩
Bulletin du Cancer, 2018, 105 (4), pp.397-407. ⟨10.1016/j.bulcan.2018.02.001⟩
Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (4), pp.397-407. ⟨10.1016/j.bulcan.2018.02.001⟩
Bulletin du Cancer, 2018, 105 (4), pp.397-407. ⟨10.1016/j.bulcan.2018.02.001⟩
Les fluoropyrimidines restent les molécules anticancéreuses les plus prescrites dans le traitement des tumeurs solides. Elles induisent des toxicités sévères chez 10–40 % des patients et des toxicités létales chez 0,2–0,8 % des patients. U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ff9e2572345bfb76a0cc72402bcf618
http://hdl.handle.net/20.500.12210/59663
http://hdl.handle.net/20.500.12210/59663
Autor:
Jean-Luc Raoul, Fadil Masskouri, S. Collette, Laurent Bedenne, Jean Claude Barbare, O. Bouche, M. Doffoel, Franck Bonnetain, Xavier Paoletti, Philippe Rougier
Publikováno v:
Quality of Life Research
Quality of Life Research, Springer Verlag, 2008, 17 (6), pp.831-843
Quality of Life Research, Springer Verlag, 2008, 17 (6), pp.831-843
The aims of our study were to assess quality of life (QoL) as a prognostic factor of overall survival (OS) and to determine whether QoL data improved three prognostic classifications among French patients with advanced hepatocellular carcinoma (HCC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08799a42f0e3806a97d9cebdc0d3a934
https://hal.archives-ouvertes.fr/hal-00363732
https://hal.archives-ouvertes.fr/hal-00363732